Benign prostatic hyperplasia as a progressive disease: a guide to the risk factors and options for medical management.

Int J Clin Pract · 2008 · PMC2440415 · PMID 18479366

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In the Alfuzosin Long-Term Efficacy and Safety Study, alfuzosin did not reduce the risk of AUR compared with placebo; although a trend towards a lower incidence of BPH-related surgery was seen in the alfuzosin group, this did not reach statistical significance when compared with the placebo group ( 41 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.